Lineage Cell Therapeutics (LCTX) Debt Ratio (2014 - 2021)

Lineage Cell Therapeutics' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.0 for Q1 2021.

• In Q1 2021, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2021 stood at 0.0 (changed N/A YoY), while the FY2020 annual figure was 0.0, changed N/A from the prior year.
• Debt Ratio for Q1 2021 stood at 0.0, down from 0.0 in the prior quarter.
• The five-year high for Debt Ratio was 0.01 in Q3 2020, with the low at 0.0 in Q4 2017.
• The 3-year median for Debt Ratio is 0.0 (2021), against an average of 0.0.
• Peak annual rise in Debt Ratio reached 70.37% in 2017, while the deepest fall reached 87.66% in 2017.
• Lineage Cell Therapeutics' Debt Ratio stood at 0.0 in 2017, then soared by 4562.96% to 0.0 in 2020, then decreased by 15.62% to 0.0 in 2021.
• Business Quant data shows LCTX's Debt Ratio at 0.0 in Q1 2021, 0.0 in Q4 2020, and 0.01 in Q3 2020.